De Felipe, Rehena .
HRN: 22-42-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2023
CEFUROXIME 1.5GM (VIAL)
02/12/2023
02/13/2023
IV
1.5
Q8
Repeat Cs
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes